Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LSC Exosome Eye Injection
- Development stage
- Preclinical
- Lead developer
- YD Bio
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
LSC Exosome Eye Injection is an exosome-based biologic therapy being developed by YD Bio in collaboration with 3D Global Biotech. The therapeutic consists of exosomes derived from limbal stem cells (LSCs), which are administered via intravitreal injection to treat inflammatory ocular conditions, including retinal and macular disorders such as age-related macular degeneration (AMD). The mechanism of action involves the delivery of bioactive molecules contained within the LSC-derived exosomes to the posterior segment of the eye to reduce ocular inflammation and promote tissue repair. As of early 2026, the program is in the preclinical stage; the developer has completed Chemistry, Manufacturing, and Controls (CMC) development and filed Drug Master Files (DMFs) with the U.S. FDA for the LSC platform and its derived products.
- Other names
- Limbal Stem Cell Exosome Eye InjectionLSC-derived exosome injection
Beyond the preview
Go deeper on LSC Exosome Eye Injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LSC Exosome Eye Injection.